ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2323

Patient Priorities in Rheumatoid Arthritis (RA) Research: An Exploration of Patient Perspectives from Those Enrolled in an Ontario RA Cohort

Laura Fullerton1, Angela Cesta2, Catherine Hoffstetter3 and Claire Bombardier2,4,5, 1Support, Systems and Outcomes, University Health Network, Toronto, ON, Canada, 2Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 3Patient partner, Toronto, ON, Canada, 4Division of Rheumatology and Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada, 5Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: patient engagement, patient-reported outcome measures, qualitative and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Health Services Research Poster III: Patient Reported Outcomes, Patient Education and Preferences

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Patient experiences with rheumatoid arthritis (RA) symptoms, treatments, and rheumatology care are critically important for the assessment of treatment-effectiveness and quality of care for RA. Despite recommendations for more patient-centered research, measures to evaluate the effectiveness of RA therapies often fail to reflect patient priorities.[1]The Ontario Best Practices Research Initiative (OBRI) is a clinical registry focused on improving the quality of care and health outcomes of patients with RA through long-term data collection on therapies, clinical practices, and health-care utilization. In OBRI, patient self-reported data is collected using structured interviews and validated questionnaires. The objectives of this study were to explore patient priorities in RA research, identify gaps in OBRI data collection, and explore options for improved data collection and communication with patients.

Methods:

RA patients enrolled in the OBRI clinical registry were invited to participate in 1 of 3 patient sessions in 2014 to provide feedback on how OBRI data collection could be improved to better capture patient needs/priorities. In small groups facilitated by a moderator, patients were asked to identify gaps in OBRI data collection, share experiences with RA and rheumatology care, and discuss priorities for RA research. In total, 48 RA patients participated in a facilitated discussion. After each session, patients completed a questionnaire on their use of social media.

Results:

Four overarching research priorities were identified: 1) A need for qualitative research focused on patient experiences with RA including: journeys to diagnosis, symptoms, treatment side effects, and challenges/concerns; 2) A need for qualitative research into patient satisfaction with rheumatology care including: rheumatologist accessibility, communication, and disease management; 3) A need for OBRI research questions addressing patient social support networks, strategies for coping with flares, diet and exercise, and the use of alternative therapies; and 4) A need for more information from rheumatologists on medication risks and side effects. Of those who completed the social media questionnaire, 100% reported regular use of email and 81% reported regular use of social networking sites, however only 54% reported a preference for research-related communication through email compared with regular postage.

Conclusion:

RA patients expressed that some of their most important disease-related experiences are not captured by structured questionnaires, suggesting a need for mixed-methods research to capture both qualitative and quantitative patient-reported outcomes. This study identifies patient research priorities and opportunities for improved care and communication.


[1] Rendas-Baum, R. et al. 2014. Measuring the effect of therapy in RA clinical trials from the patient’s perspective. Curr Med Res Opin. 1-13.


Disclosure: L. Fullerton, None; A. Cesta, None; C. Hoffstetter, None; C. Bombardier, None.

To cite this abstract in AMA style:

Fullerton L, Cesta A, Hoffstetter C, Bombardier C. Patient Priorities in Rheumatoid Arthritis (RA) Research: An Exploration of Patient Perspectives from Those Enrolled in an Ontario RA Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/patient-priorities-in-rheumatoid-arthritis-ra-research-an-exploration-of-patient-perspectives-from-those-enrolled-in-an-ontario-ra-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-priorities-in-rheumatoid-arthritis-ra-research-an-exploration-of-patient-perspectives-from-those-enrolled-in-an-ontario-ra-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology